The UK has introduced a new amendment to the Cosmetics Regulation (SI 2026/109), bringing important updates to Annex II and Annex III. Among the key changes, Hexyl Salicylate has been added to Annex III with specific restrictions, alongside the ban of 13 additional substances. With compliance deadlines now set, companies placing products on the UK market should review formulations and portfolios to ensure timely alignment.

White label cosmetics are not exempt from regulatory frameworks simply because a third party makes them. Legal responsibility attaches to the entity that places the branded product on the market and/or is named on the label under each jurisdiction’s laws. Understanding and mapping those roles across markets is essential for compliance and risk management.

One of the most common global compliance risks in private label models is the misalignment of legal responsibilities. Confusion often arises between branding, distribution, and regulatory accountability. For this reason, clearly designating the accountable entity and documenting the allocation of regulatory responsibilities are essential steps to ensure compliant market access.

The US beauty market offers significant growth opportunities, but success requires more than strong branding. In this article, we share key insights from our presentation at Cosme Week Tokyo 2026, covering US consumer trends, the rise of clean and ingredient focused beauty, the growing influence of Amazon, and the essential regulatory requirements under MoCRA and state level laws. Discover what brands need to know before entering the US market.

Learn what a cosmetic safety assessment is in the EU, including CPSR requirements, qualified safety assessor roles, and compliance obligations under Regulation (EC) No 1223/2009.

The SCCS has issued a preliminary safety assessment on thiomersal and phenylmercuric salts – understand the scientific concerns and potential regulatory consequences for cosmetics.